Page 1221 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

4 References

94. Roberts PA, Pollay M, Engles C, Pendleton B, Reynolds E, 112. Qureshi AI, Wilson DA, Traystman RJ. Treatment of ele-
Stevens FA. Effect on intracranial pressure of furosemide com- vated intracranial pressure in experimental intracerebral
bined with varying doses and administration rates of mannitol. hemorrhage: comparison between mannitol and hypertonic
J Neurosurg. March 1987;66(3):440-446. saline. Neurosurgery. May 1999;44(5):1055-1063; discussion
95. Shackford SR, Norton CH, Todd MM. Renal, cerebral, and pul- 1063-1054.
monary effects of hypertonic resuscitation in a porcine model of 113. White H, Cook D, Venkatesh B. The use of hypertonic saline for
hemorrhagic shock. Surgery. September 1988;104(3):553-560. treating intracranial hypertension after traumatic brain injury.
96. Smith HP, Kelly DL Jr, McWhorter JM, et al. Comparison Anesth Analg. June 2006;102(6):1836-1846.
of mannitol regimens in patients with severe head injury 114. Battison C, Andrews PJ, Graham C, Petty T. Randomized, con-
undergoing intracranial monitoring. J Neurosurg. December trolled trial on the effect of a 20% mannitol solution and a 7.5%
1986;65(6):820-824. saline/6% dextran solution on increased intracranial pressure
97. Kofke WA. Mannitol: potential for rebound intracranial hyper- after brain injury. Crit Care Med. January 2005;33(1):196-202;
tension? J Neurosurg Anesthesiol. January 1993;5(1):1-3. discussion 257-198.
98. Rudehill A, Gordon E, Ohman G, Lindqvist C, Andersson P. 115. Harutjunyan L, Holz C, Rieger A, Menzel M, Grond S, Soukup
Pharmacokinetics and effects of mannitol on hemodynamics, J. Efficiency of 7.2% hypertonic saline hydroxyethyl starch
blood and cerebrospinal fluid electrolytes, and osmolality 200/0.5 versus mannitol 15% in the treatment of increased
during intracranial surgery. J Neurosurg Anesthesiol. January intracranial pressure in neurosurgical patients: a random-
1993;5(1):4-12. ized clinical trial [ISRCTN62699180]. Crit Care. October 5,
2005;9(5):R530-R540.
99. Frank JI. Large hemispheric infarction, deterioration, and intra-
cranial pressure. Neurology. July 1995;45(7):1286-1290. 116. Ichai C, Armando G, Orban JC, et al. Sodium lactate versus
100. Paczynski RP, He YY, Diringer MN, Hsu CY. Multiple-dose mannitol in the treatment of intracranial hypertensive episodes
mannitol reduces brain water content in a rat model of cortical in severe traumatic brain-injured patients. Intensive Care Med.
infarction. Stroke. July 1997;28(7):1437-1443; discussion 1444. March 2009;35(3):471-479.
101. Jennett B, Teasdale GM. Management of Head Injuries. 117. Schwarz S, Schwab S, Bertram M, Aschoff A, Hacke W. Effects
Philadelphia, PA: FA Davis; 1981:204-241. of hypertonic saline hydroxyethyl starch solution and mannitol
in patients with increased intracranial pressure after stroke.
102. Cold GE. Cerebral blood flow in acute head injury. The regula- Stroke. August 1998;29(8):1550-1555.
tion of cerebral blood flow and metabolism during the acute
phase of head injury, and its significance for therapy. Acta 118. Vialet R, Albanese J, Thomachot L, et al. Isovolume hypertonic
Neurochir Suppl (Wien). 1990;49:1-64. solutes (sodium chloride or mannitol) in the treatment of
refractory posttraumatic intracranial hypertension: 2 mL/kg
103. James HE. Methodology for the control of intracranial pressure 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit
with hypertonic mannitol. Acta Neurochir (Wien). 1980;51(3-4): Care Med. June 2003;31(6):1683-1687.
161-172.
119. Kamel H, Navi BB, Nakagawa K, Hemphill JC 3rd, Ko NU.
104. Schierhout G, Roberts I. Mannitol for acute traumatic brain Hypertonic saline versus mannitol for the treatment of elevated
injury. Cochrane Database Syst Rev. 2000;(2):CD001049. intracranial pressure: a meta-analysis of randomized clinical
105. Horn P, Munch E, Vajkoczy P, et al. Hypertonic saline solution trials. Crit Care Med. March 2011;39(3):554-559.
for control of elevated intracranial pressure in patients with
exhausted response to mannitol and barbiturates. Neurol Res. 120. Schurr A. Lactate, glucose and energy metabolism in the isch-
December 1999;21(8):758-764. emic brain (Review). Int J Mol Med. August 2002;10(2):131-136.
106. Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of hyper- 121. Schurr A, Payne RS, Miller JJ, Rigor BM. Brain lactate is an
tonic (10%) saline in patients with raised intracranial pressure obligatory aerobic energy substrate for functional recovery
after stroke. Stroke. January 2002;33(1):136-140. after hypoxia: further in vitro validation. J Neurochem. July
1997;69(1):423-426.
107. Shaywitz BA, Rothstein P, Venes JL. Monitoring and manage-
ment of increased intracranial pressure in Reye syndrome: 122. Rice AC, Zsoldos R, Chen T, et al. Lactate administration
results in 29 children. Pediatrics. August 1980;66(2):198-204. attenuates cognitive deficits following traumatic brain injury.
Brain Res. February 22, 2002;928(1-2):156-159.
108. Worthley LI, Cooper DJ, Jones N. Treatment of resistant intra-
cranial hypertension with hypertonic saline. Report of two 123. Wilkinson HA, Wepsic JG, Austin G. Diuretic synergy in the
cases. J Neurosurg. March 1988;68(3):478-481. treatment of acute experimental cerebral edema. J Neurosurg.
February 1971;34(2, pt 1):203-208.
109. Bloch M. Cerebral effects of rewarming following prolonged
hypothermia: significance for the management of severe 124. Suarez JI. [Management of closed head injury]. Rev Neurol.
cranio-cerebral injury and acute pyrexia. Brain. December February 1-15, 2001;32(3):289-295.
1967;90(4):769-784. 125. Raslan A, Bhardwaj A. Medical management of cerebral edema.
110. Rockswold GL, Solid CA, Paredes-Andrade E, Rockswold SB, Neurosurg Focus. 2007;22(5):E12.
Jancik JT, Quickel RR. Hypertonic saline and its effect on intra- 126. Hata JS, Shelsky CR, Hindman BJ, Smith TC, Simmons JS, Todd
cranial pressure, cerebral perfusion pressure, and brain tissue MM. A prospective, observational clinical trial of fever reduc-
oxygen. Neurosurgery. December 2009;65(6):1035-1041; discus- tion to reduce systemic oxygen consumption in the setting of
sion 1041-1032. acute brain injury. Neurocrit Care. 2008;9(1):37-44.
111. Qureshi AI, Suarez JI. Use of hypertonic saline solutions in 127. Polderman KH. Induced hypothermia and fever control for
treatment of cerebral edema and intracranial hypertension. Crit prevention and treatment of neurological injuries. Lancet. June
Care Med. September 2000;28(9):3301-3313. 7 2008;371(9628):1955-1969.

Section06-O-ref.indd 4 12/10/2014 6:03:40 PM